Last reviewed · How we verify

Endoscopic injection of Indocyanine green

Ukrainian Society of Clinical Oncology · Phase 3 active Small molecule

Endoscopic injection of Indocyanine green is a Fluorescent imaging agent Small molecule drug developed by Ukrainian Society of Clinical Oncology. It is currently in Phase 3 development for Intraoperative visualization during endoscopic oncologic surgery, Sentinel lymph node identification in cancer surgery.

Indocyanine green is a near-infrared fluorescent dye injected endoscopically to enable real-time visualization of tissue perfusion and lymphatic drainage during surgical procedures.

Indocyanine green is a near-infrared fluorescent dye injected endoscopically to enable real-time visualization of tissue perfusion and lymphatic drainage during surgical procedures. Used for Intraoperative visualization during endoscopic oncologic surgery, Sentinel lymph node identification in cancer surgery.

At a glance

Generic nameEndoscopic injection of Indocyanine green
SponsorUkrainian Society of Clinical Oncology
Drug classFluorescent imaging agent
ModalitySmall molecule
Therapeutic areaOncology
PhasePhase 3

Mechanism of action

Indocyanine green (ICG) is a tricarbocyanine dye that fluoresces in the near-infrared spectrum when excited by appropriate wavelengths. When injected endoscopically, it binds to plasma proteins and accumulates in tissues, allowing surgeons to visualize vascular perfusion, identify sentinel lymph nodes, and delineate tumor margins in real-time using specialized imaging equipment. This enhanced visualization aids in surgical guidance and completeness of resection in oncologic procedures.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Endoscopic injection of Indocyanine green

What is Endoscopic injection of Indocyanine green?

Endoscopic injection of Indocyanine green is a Fluorescent imaging agent drug developed by Ukrainian Society of Clinical Oncology, indicated for Intraoperative visualization during endoscopic oncologic surgery, Sentinel lymph node identification in cancer surgery.

How does Endoscopic injection of Indocyanine green work?

Indocyanine green is a near-infrared fluorescent dye injected endoscopically to enable real-time visualization of tissue perfusion and lymphatic drainage during surgical procedures.

What is Endoscopic injection of Indocyanine green used for?

Endoscopic injection of Indocyanine green is indicated for Intraoperative visualization during endoscopic oncologic surgery, Sentinel lymph node identification in cancer surgery.

Who makes Endoscopic injection of Indocyanine green?

Endoscopic injection of Indocyanine green is developed by Ukrainian Society of Clinical Oncology (see full Ukrainian Society of Clinical Oncology pipeline at /company/ukrainian-society-of-clinical-oncology).

What drug class is Endoscopic injection of Indocyanine green in?

Endoscopic injection of Indocyanine green belongs to the Fluorescent imaging agent class. See all Fluorescent imaging agent drugs at /class/fluorescent-imaging-agent.

What development phase is Endoscopic injection of Indocyanine green in?

Endoscopic injection of Indocyanine green is in Phase 3.

What are the side effects of Endoscopic injection of Indocyanine green?

Common side effects of Endoscopic injection of Indocyanine green include Allergic reaction, Anaphylaxis, Transient hypotension.

Related